Researchers
Đorđević, Nataša
Results 1-20 of 99
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | An Implantable Loop Recorder in the Diagnosis of Cardiac Arrhythmias: The Importance of Drug Treatment in Predicting Pacemaker Requirement | Vuckovic-Filipovic, Jelena; Ignjatovic, Vladimir S | Article | 21M21 |
| 2025 | ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children![]() | Đorđević, Nataša D. | Article | Mp. category will be shown later |
| 2025 | Chlamydia trachomatis-Specific Antibodies and In Vitro Fertilization Outcome | Djordjevic, Natasa D | Article | 21M21 |
| 2025 | F5 6665A>G Polymorphism Is Associated with Increased Risk of Venous Thromboembolism in Females | Teofilov, Sladjana; Miljanovic, Olivera; Vuckovic-Filipovic, Jelena; Djordjevic, Natasa D | Article | 21M21 |
| 2024 | case-control study of association of FV HR2 6775A > G polymorphisms with thrombosis in Montenegrin patients; Haplotype analysis between FV 1691G > A and FV HR2 6775A > G polymorphisms | Teofilov, Sladjana; Miljanovic, Olivera; Ostojic, Tatjana; Bulatovic, Milena; Perovic, Sasa; Djordjevic, Natasa | Conference Paper | Mp. category will be shown later |
| 2024 | A case-control study of association of FV HR2 6775A > G polymorphisms with thrombosis in Montenegrin patients; Haplotype analysis between FV 1691G > A and FV HR2 6775A > G polymorphisms | Teofilov, Sladjana; Miljanovic, Olivera; Ostojic, Tatjana; Bulatovic, Milena; Perovic, Sasa; Djordjevic, Natasa D | Conference Paper | Mp. category will be shown later |
| 2024 | Effectiveness of the first and the second dose of COVID-19 vaccines in Serbia during the first three months of rollout![]() | Đorđević, Nataša | Article | 23M23 |
| 2024 | Protective Effect of Hyperprolactinemia on Oxidative Stress in Patients with Psychotic Disorder on Atypical Antipsychotics Risperidone and Paliperidone: A Cross-Sectional Study | Stojkovic, Milena; Jovanovic, Mirjana R | Article | 21M21 |
| 2024 | ACE2 and TMPRSS2 genetic polymorphisms as potential predictors of COVID-19 severity and outcome in females![]() | Matic, Sanja | Article | 21aM21a |
| 2023 | IFNL3/4</i> polymorphisms as a two‐edged sword: An association with COVID‐19 outcome![]() | Sanja Matic | Article | 21a+M21a+ |
| 2023 | Effectiveness of a third dose of COVID-19 vaccines against delta variant of SARS-COV-2: A Serbian cohort study![]() | Đorđević, Nataša | Article | 23M23 |
| 2023 | Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives | Djordjevic, Natasa | Reviews | 21M21 |
| 2023 | Silent SARS-CoV-2 infection: seroprevalence study of SARS-CoV-2 anti- nucleocapsid IgG antibodies in Kragujevac, Serbia | Cicaric, Neda; Canovic, Vanja R | Article | 23M23 |
| 2023 | Its all about IFN‐λ4: Protective role of IFNL4 polymorphism against COVID‐19‐related pneumonia in females![]() | Matic, Sanja | Article | 21a+M21a+ |
| 2022 | SUPEROXIDE DISMUTASE 2 VAL16ALA POLYMORPHISM IS ASSOCIATED WITH AMIODARONE-ASSOCIATED LIVER INJURY![]() | Djordjevic, Natasa | Article | 51M51 |
| 2022 | Anxiety in patients treated in a temporary hospital in Belgrade, Serbia, during the first epidemic wave of COVID-19 | Makević A.; Ilic A.; Pantovic Stefanovic M.; Muric, Nemanja | Article | 21aM21a |
| 2022 | Total costs of inpatient treatment for COVID-19 in a tertiary hospital in Serbia | Sazdanovic, Predrag S; Milisavljevic, Slobodan S; Milovanovic, Dragan R | Article | 22M22 |
| 2022 | Risk factors for adverse drug reactions associated with clopidogrel therapy | Mugoša S.; Radosavljevic, Ivan | Article | 21M21 |
| 2021 | TREATMENT COSTS FOR COVID-19 PATIENTS IN A TERTIARY HOSPITAL FROM SERBIA![]() | Sazdanovic, P.S. | Other | Mp. category will be shown later |
| 2021 | ABCB1 polymorphism in clopidogrel-treated Montenegrin patients![]() | Mugoša, Snežana; Todorović, Zoran M. | Article | 22M22 |
